CORONA REMEDIES LIMITED

CORONA

Small Cap | Pharmaceuticals
1580
-7.19 (-0.45%)

Stock price as on 02 Mar 2026 at 15:30 PM

Corona remedies limited share price update

As of the latest trading session, Corona Remedies Limited share price is currently at ₹1580, which is down by ₹-7.19 from its previous closing. Today ...

Corona Remedies Limited stock performance

Today’s low

₹1,513.1

Today’s high

₹1,615

₹1,580

52 week low

₹1,336.6

52 week high

₹1,660.8

₹1,580
Open
₹1,513.20
Previous close
₹1,587.20
Share volume
14,028
Total traded value (Lakh)
₹226.55
Upper circuit
₹1,904.60
Lower circuit
₹1,269.80

Corona Remedies Limited fundamentals

Market cap (Cr)
₹9,663.30
P/E ratio (TTM)
56.5
Book value per share
₹107.75
Beta
0.83
Return on equity
27.45%
Earnings per share (TTM)
₹30.14
Dividend yield
0.46%
Net profit/quarter (Cr)
₹41.25

Corona Remedies Limited financials

(Values in Cr)
Revenue
Net income

Particulars

Dec 25 (₹ value in crores)

Revenue

₹342.42

Operating expense

₹270.37

Net income

₹41.25

Net profit margin

12.04%

Earning per share

₹6.74

EBITDA

₹66.30

Effective tax rate

25.25%

Particulars

Sep 25 (₹ value in crores)

Revenue

₹361.13

Operating expense

₹293.79

Net income

₹52.15

Net profit margin

14.44%

Earning per share

₹8.53

EBITDA

₹80.74

Effective tax rate

25.08%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹346.54

Operating expense

₹287.67

Net income

₹46.40

Net profit margin

13.38%

Earning per share

₹7.59

EBITDA

₹71.80

Effective tax rate

23.79%

Particulars

Mar 25 (₹ value in crores)

Revenue

₹293.69

Operating expense

-

Net income

₹31.34

Net profit margin

10.67%

Earning per share

₹5.12

EBITDA

-

Effective tax rate

-

Particulars

Dec 24 (₹ value in crores)

Revenue

₹297.69

Operating expense

₹240.35

Net income

₹44.77

Net profit margin

15.03%

Earning per share

₹7.32

EBITDA

₹70.18

Effective tax rate

22.94%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹1,196.42

Operating expense

₹1,004.20

Net income

₹149.05

Net profit margin

12.45%

Earning per share

₹24.37

EBITDA

₹245.91

Effective tax rate

24.77%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹99.14

Return on Equity (ROE)

27.5%

Return on Capital Employed (ROCE)

29.82%

Total debt to equity ratio

0.23

EBITDA margin

20.59%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹78.55

Return on Equity (ROE)

20.36%

Return on Capital Employed (ROCE)

23.46%

Total debt to equity ratio

0.21

EBITDA margin

15.89%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹66.80

Return on Equity (ROE)

20.79%

Return on Capital Employed (ROCE)

24.94%

Total debt to equity ratio

0.07

EBITDA margin

15.3%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹99.04

Return on Equity (ROE)

27.45%

Return on Capital Employed (ROCE)

29.78%

Total debt to equity ratio

0.23

EBITDA margin

20.55%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹78.51

Return on Equity (ROE)

20.38%

Return on Capital Employed (ROCE)

23.47%

Total debt to equity ratio

0.21

EBITDA margin

15.89%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹66.70

Return on Equity (ROE)

23.24%

Return on Capital Employed (ROCE)

27.29%

Total debt to equity ratio

0.08

EBITDA margin

15.27%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹62.86

Return on Equity (ROE)

-0.18%

Return on Capital Employed (ROCE)

0.95%

Total debt to equity ratio

0.13

EBITDA margin

3.93%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹727.91

Return on Equity (ROE)

23.09%

Return on Capital Employed (ROCE)

25.14%

Total debt to equity ratio

0.16

EBITDA margin

19.15%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹69.27

Total assets

₹929.86

Total liabilities

₹929.86

Total equity

₹606.34

Shares outstanding

₹6.11

Price to book ratio

-

Return on assets (%)

16.07%

Return on capital

22.34%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹69.90

Total assets

₹830.57

Total liabilities

₹830.57

Total equity

₹480.40

Shares outstanding

₹6.11

Price to book ratio

-

Return on assets (%)

10.89%

Return on capital

14.73%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹76.69

Total assets

₹595.02

Total liabilities

₹595.02

Total equity

₹408.52

Shares outstanding

₹6.11

Price to book ratio

-

Return on assets (%)

14.27%

Return on capital

20.67%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹69.27

Total assets

₹929.24

Total liabilities

₹929.24

Total equity

₹605.72

Shares outstanding

₹6.11

Price to book ratio

-

Return on assets (%)

16.03%

Return on capital

22.3%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹69.90

Total assets

₹830.34

Total liabilities

₹830.34

Total equity

₹480.17

Shares outstanding

₹6.11

Price to book ratio

-

Return on assets (%)

10.89%

Return on capital

14.73%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹76.69

Total assets

₹594.79

Total liabilities

₹594.79

Total equity

₹408.29

Shares outstanding

₹6.11

Price to book ratio

-

Return on assets (%)

14.24%

Return on capital

20.63%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹100.97

Total assets

₹511.36

Total liabilities

₹511.36

Total equity

₹320.90

Shares outstanding

₹5.10

Price to book ratio

-

Return on assets (%)

-0.07%

Return on capital

-0.11%

Particulars

Mar 20 (₹ value in crores)

Cash and short term investments

₹39.55

Total assets

₹396.31

Total liabilities

₹396.31

Total equity

₹269.15

Shares outstanding

₹0.46

Price to book ratio

-

Return on assets (%)

14.98%

Return on capital

19.01%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹198.53

Cash from operations

₹233.77

Cash from investing

-₹83.84

Cash from financing

-₹106.58

Net change in cash

₹0.06

Free cash flow

₹325.41

Particulars

Mar 24 (₹ value in crores)

Net income

₹118.48

Cash from operations

₹174.66

Cash from investing

-₹266.64

Cash from financing

₹98.54

Net change in cash

-₹11.34

Free cash flow

₹461.00

Particulars

Mar 23 (₹ value in crores)

Net income

₹110.88

Cash from operations

₹128.52

Cash from investing

-₹50.24

Cash from financing

-₹44.74

Net change in cash

₹7.70

Free cash flow

₹223.27

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹198.14

Cash from operations

₹233.77

Cash from investing

-₹83.83

Cash from financing

-₹106.58

Net change in cash

₹0.06

Free cash flow

₹325.42

Particulars

Mar 24 (₹ value in crores)

Net income

₹118.47

Cash from operations

₹174.66

Cash from investing

-₹266.64

Cash from financing

₹98.54

Net change in cash

-₹11.34

Free cash flow

₹461.00

Particulars

Mar 23 (₹ value in crores)

Net income

₹110.66

Cash from operations

₹128.52

Cash from investing

-₹50.24

Cash from financing

-₹44.74

Net change in cash

₹7.70

Free cash flow

₹223.28

Particulars

Mar 22 (₹ value in crores)

Net income

-₹0.79

Cash from operations

₹99.20

Cash from investing

-₹65.77

Cash from financing

-₹29.85

Net change in cash

₹2.03

Free cash flow

₹133.20

Particulars

Mar 20 (₹ value in crores)

Net income

₹78.34

Cash from operations

₹60.19

Cash from investing

-₹50.24

Cash from financing

₹32.40

Net change in cash

₹22.92

Free cash flow

₹60.19

Corona Remedies Limited technical summary

₹1580
-0.45 ▼
5
Bearish
11
Bullish
5 Day1,593.6
10 Day1,584.8
12 Day1,580.5
20 Day1,560.8
26 Day1,545.9
50 Day1,484.4
100 Day1,476.7
200 Day1,476.7
5 Day1,597.6
10 Day1,578.9
12 Day1,583
20 Day1,568.6
26 Day1,540
50 Day1,479.6
100 Day0
200 Day0

1591.33

PIVOT

First support
₹0.00
First resistance
₹0.00
Second support
₹0.00
Second resistance
₹0.00
Third support
₹0.00
Third resistance
₹0.00
RSI
55.7
ADX
38.37
MACD
34.66
Williams % R
-46.17
Commodity Channel Index (CCI)
39.43
Date
27 Feb 2026
Same day
4,484
Week
7,607
Month
16,182
1 year
0.83
3 years
0.83
Over 1 month
11.8%
Over 1 year
0%
Over 3 months
10.34%
Over 3 years
0%
Over 6 months
0%
Over 6 years
0%

Investment Returns

Over 1 Month11.8%
Over 3 Months10.34%
Over 6 Months0%
Over 1 Year0%

Corona Remedies Limited Shareholding pattern


Public
22.4%
Promoter holdings
68.99%
FII
1.83%
DII
6.76%
Promoter shares
0%
Promoter sharesShareCategory

Nirav Kirtikumar Mehta

1,34,58,000 (22%)

Shareholding of Promoter and Promoter Group

Ankurbhai K Mehta

1,34,58,000 (22%)

Shareholding of Promoter and Promoter Group

Kirtikumar Laxmidas Mehta

1,22,29,307 (20%)

Shareholding of Promoter and Promoter Group

Sepia Investments Limited

1,20,84,729 (19.76%)

Public Shareholding

Invesco India Multicap Fund

24,96,458 (4.08%)

Public Shareholding

Promoter sharesShareCategory
Nirav Kirtikumar Mehta1,34,58,000 (22%)Shareholding of Promoter and Promoter Group
Ankurbhai K Mehta1,34,58,000 (22%)Shareholding of Promoter and Promoter Group
Kirtikumar Laxmidas Mehta1,22,29,307 (20%)Shareholding of Promoter and Promoter Group
Sepia Investments Limited1,20,84,729 (19.76%)Public Shareholding
Invesco India Multicap Fund24,96,458 (4.08%)Public Shareholding
Brinda Ankur Mehta12,22,047 (2%)Shareholding of Promoter and Promoter Group
Dipaben Niravkumar Mehta12,22,047 (2%)Shareholding of Promoter and Promoter Group
Minaxi Kirtikumar Mehta6,08,567 (1%)Shareholding of Promoter and Promoter Group

About CORONA REMEDIES LIMITED

Corona Remedies Limited was originally incorporated as CORONA Remedies Private Limited', a private limited company, dated August 27, 2004, issued by the Assistant Registrar of Companies, Gujarat at Dadra and Nagar Haveli. Thereafter, Company converted into a public limited and Company name has changed to CORONA Remedies Limited'. A fresh certificate of incorporation, is issued by the Registrar of Companies, Central Processing Centre, Manesar, Haryana on December 16, 2024. The manufacturing facilities of the Company are located at Solan (Hima

Parent Organisation

Indian Private

NSE Symbol

CORONA

Founded

2004

CORONA REMEDIES LIMITED CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

TRUEGREEN

TRUE GREEN BIO ENERGY LIMITED

108.86
+18.14 (+20%)
LIMECHM

LIME CHEMICALS LTD.

17.43
+2.9 (+19.96%)
KALANA

KALANA ISPAT LIMITED

23.5
+3.9 (+19.9%)
VEERKRUPA

VEERKRUPA JEWELLERS LIMITED

0.71
+0.11 (+18.33%)
View all

Top gainers

BEL

BHARAT ELECTRONICS LTD

453.95
+9.25 (+2.08%)
HINDALCO

HINDALCO INDUSTRIES LTD

940
+15.30 (+1.65%)
ONGC

OIL AND NATURAL GAS CORP.

282.2
+2.50 (+0.89%)
SUNPHARMA

SUN PHARMACEUTICAL IND L

1752.5
+15.50 (+0.89%)
View all

Top losers

INDIGO

INTERGLOBE AVIATION LTD

4520.4
-306.80 (-6.36%)
LT

LARSEN & TOUBRO LTD.

4066.7
-211.60 (-4.95%)
ADANIPORTS

ADANI PORT & SEZ LTD

1470.3
-50.70 (-3.33%)
MARUTI

MARUTI SUZUKI INDIA LTD.

14388
-469.00 (-3.16%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)